News
🇺🇸 FDA Page 4Latest pharmaceutical news, drug approvals, and FDA regulatory updates
Showing 37–48 of 807 articles
AstraZeneca expands obesity push as it invests $125M in ultrasound medicine
FDA · obesity · 5 min
Dr. Sarah MitchellFDA Drug Approval: What Approval Means for Pharma Marketing and BD
FDA · 5 min
Dr. Sarah MitchellFDA investigates Salmonella in moringa leaf powder, expands recall
FDA · Salmonella · 4 min
Dr. Sarah MitchellNektar Therapeutics pipeline update: REZPEG, amphotericin B and UK site changes
6 min
Dr. Sarah MitchellVanda tradipitant update: FDA re-review extends to Dec. 5, 2025
FDA · 6 min
Dr. Sarah MitchellSanofi pipeline pdf: Dupixent, Lantus and 2026 catalysts
5 min
Dr. Sarah MitchellCardiff Oncology pipeline update: onvansertib trials, FDA meeting, and catalysts
FDA · oncology · 5 min
Dr. Sarah MitchellAlnylam pipeline update: AMVUTTRA catalysts, outlook and profitability
U.S. FDA · ATTR-CM · 5 min
Dr. Sarah MitchellNeurocrine Biosciences pipeline update: what analysts should watch next
neurology · 7 min
Dr. Sarah MitchellArcus Biosciences pipeline update: casdatifan, quemliclustat, domvanalimab
kidney cancer · 4 min
Dr. Sarah MitchellSyndax pipeline update: Revuforj and Niktimvo catalysts to watch
FDA · 8 min
Dr. Sarah MitchellTillomed Laboratories update: pipeline, melphalan and next catalysts
oncology · 6 min
Dr. Sarah MitchellPopular topics
- Drug Approvals 1,128 articles
- Clinical Trials 634 articles
- Regulatory Updates 687 articles
- FDA News 502 articles
- Press Releases 443 articles
- Oncology 443 articles
- Rare Diseases 141 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways